Park Square Financial Group, LLC

Position in LLY — ELI LILLY & Co

CIK 2058285 ROSWELL, GA

Position in LLY

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$143,930

+$28,960 QoQ

Shares Held

120

-4.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

5.54%

of 13F equity value

Holder Rank

#4,466

of 4,605 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Park Square Financial Group, LLC holds $191,148 across 6 Drug Manufacturers - General names. LLY ranks #1 (75.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	120	$143,930
2	JNJ	Johnson & Johnson	81	$20,571
3	MRK	Merck & Co., Inc.	76	$9,766
4	AZN	Astrazeneca PLC	43	$8,153
5	GILD	Gilead Sciences, Inc.	48	$6,064
6	NVS	Novartis AG	17	$2,664

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$143,930	120	-4.0%	Shares	Sole	2026-07-31
2026-03-31	$114,970	125	-8.1%	Shares	Sole	2026-05-13
2025-12-31	$146,156	136	-0.7%	Shares	Sole	2026-02-05
2025-09-30	$104,531	137	-90.8%	Shares	Sole	2025-11-12
2025-06-30	$1,163,836	1,493	+2.0%	Shares	Sole	2025-08-12
2025-03-31	$1,209,132	1,464	-7.2%	Shares	Sole	2025-05-01
2024-12-31	$1,217,444	1,577	—	Shares	Sole	2025-02-28
No filing history on record for this holder in this stock.